Featured Insights
Overweight S&P Biotech
We doubt the merger mania is over and we continue to believe that more mega deals are in store, either intra or inter-industry, with Big Pharma hungry and in a hurry to replenish their drug pipeline. From a long-term macro perspective, biotech stocks…
Interested in reading the full Daily Insight?
Read the full insight with instant access.
BCA Research | Daily Insights
Stay on top of market events and BCA's latest ideas, with high value, timely insights delivered to your inbox daily.
Stay Connected with BCA
Get our latest events and research insights delivered to your inbox.